Acute Basilar Artery Occlusion: Endovascular Interventions vs Standard Medical Treatment

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 131 participants.

Also called NCT02441556

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 131 participants (enrolled count) (from the registry)
Sponsor
Xinfeng Liu (from the registry)
Registry
  • NCT NCT02441556
Other papers using this trial's data
  • Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial The Lancet. Neurology, 2020-02 DOI, PubMed 31831388

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02441556. Randomized; no masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2017-09-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Acute Basilar Artery Occlusion: Endovascular Interventions vs Standard Medical Treatment
Acronym
BEST
Condition
Stroke Due to Basilar Artery Occlusion
Condition
Acute Cerebrovascular Accidents
Intervention (Device)
endovascular treatment
Intervention (Other)
standard medical therapy
Lead sponsor
Xinfeng Liu (class: other)

Record details

Record id
cardio:ct-nct02441556
Content hash
27135e83b75d8824ecbfa0b70bebae3a4a3f2c4a301500fae43b1f68b0ccd8af